October JAAD: Routine rescreening for latent tuberculosis has low utility in patients with chronic immune- mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study
Dec 1, 2022
Episode Description
Anthony P. Fernandez, MD, FAAD and Urmi Khanna, MD interviewed by Brad Glick, DO, MPH, FAAD
Proudly Supported by
